Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Intensive Care Medicine
Published in: Intensive Care Medicine 5/2010

Open Access 01-05-2010 | Correspondence

Subcutaneous glucose measurements and glucose regulation (?)

Authors: Jack J. Ligtenberg, Hella F. Borggreve, Arjanne Stemerdink, Jan G. Zijlstra

Published in: Intensive Care Medicine | Issue 5/2010

Login to get access

Excerpt

Sir: Andrea Stoszkova et al. [1] conclude, based on a correlation coefficient of 0.69 comparing subcutaneous glucose values (Guardian RT) and blood glucose values (Central Laboratory) in 15 patients, that subcutaneous devices should not be used in critically ill patients. However, Holzinger et al. [2] in the August issue report a good correlation between subcutaneous and arterial glucose values, even in critically ill patients treated with norepinephrine. …
Literature
1.
Stoszkova A, Dostal P, Musil F, Smahelova A, Zadak Z, Cerny V (2009) Blood and tissue glucose level in critically ill patients: a comparison of different methods of measuring interstitial glucose levels. Intensive Care Med 35:1318CrossRef
2.
Holzinger U, Warszawska J, Kitzberger R, Herkner H, Metnitz PG, Madl C (2009) Impact of shock requiring norepinephrine on the accuracy and reliability of subcutaneous continuous glucose monitoring. Intensive Care Med 35:1383–1389CrossRefPubMed
3.
Corstjens AM, Ligtenberg JJ, Horst ICC, Spanjersberg R, Lind JSW, Tulleken J, Meertens JH, Zijlstra JG (2006) Accuracy and feasibility of point-of-care and continuous blood glucose analyzing in critically ill ICU patients. Crit Care 10:R135CrossRefPubMed
4.
Vogelzang M, Loef BG, Regtien JG, van der Horst IC, van Assen H, Zijlstra F, Nijsten MW (2008) Computer-assisted glucose control in critically ill patients. Intensive Care Med 34:1421–1427CrossRefPubMed
5.
Vogelzang M, Ligtenberg JJ (2007) Practical aspects of implementing tight glucose control in the ICU. Curr Opin Clin Nutr Metab Care 10:178–180CrossRefPubMed
Metadata
Title
Subcutaneous glucose measurements and glucose regulation (?)
Authors
Jack J. Ligtenberg
Hella F. Borggreve
Arjanne Stemerdink
Jan G. Zijlstra
Publication date
01-05-2010
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 5/2010
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-010-1779-7

Other articles of this Issue 5/2010

Intensive Care Medicine 5/2010 Go to the issue

Review

Lipid emulsions in parenteral nutrition of intensive care patients: current thinking and future directions

Pediatric Original

Electrocardiographic effects of dexmedetomidine in patients with congenital heart disease

Experimental

Hypercapnic acidosis in ventilator-induced lung injury

Editorial

The worst is yet to come. Many elderly patients with chronic terminal illnesses will eventually die in the emergency department

Original

Microbiogical data, but not procalcitonin improve the accuracy of the clinical pulmonary infection score

Correspondence

Reply to Hurley